Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Davis

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Open Forum Infectious Diseases|June 10, 2024
Shared Vision for Improving Outcomes for Serious Fungal Diseases: Report of a Patient, Caregiver, and Clinician SummitRob Purdie, Lisa A Tushla, Jonathan Ferretti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patientsMichael A Morse, Robert Chapman, John Powderly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I studyCharles F Eisenbeis, Andrew Grainger, Beth Fischer, et al.
Science Translational Medicine|April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology|August 6, 2009
Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research WorkshopIgor Linkov, Jeffery Steevens, Gitanjali Adlakha-Hutcheon, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2003
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patientsF Stephen Hodi, Martin C Mihm, Robert J Soiffer, et al.
Malaria Journal|November 14, 2025
Epidemiological stratification and sub-national tailoring of malaria interventions in LiberiaVictor S Koko, D Levi Hinneh, Odell Kumeh, et al.
Journal of Clinical Microbiology|August 13, 2010
Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approachesFred C Tenover, Susan Novak-Weekley, Christopher W Woods, et al.
Nature Medicine|December 3, 2013
Self-renewal as a therapeutic target in human colorectal cancerAntonija Kreso, Peter van Galen, Nicholas M Pedley, et al.
Journal for Immunotherapy of Cancer|June 27, 2017
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31<sup>st</sup>Annual Meeting of the Society for Immunotherapy of Cancer, 2016Prasad S Adusumilli, Edward Cha, Mark Cornfeld, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Open Forum Infectious Diseases|June 10, 2024
Shared Vision for Improving Outcomes for Serious Fungal Diseases: Report of a Patient, Caregiver, and Clinician SummitRob Purdie, Lisa A Tushla, Jonathan Ferretti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patientsMichael A Morse, Robert Chapman, John Powderly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I studyCharles F Eisenbeis, Andrew Grainger, Beth Fischer, et al.
Science Translational Medicine|April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology|August 6, 2009
Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research WorkshopIgor Linkov, Jeffery Steevens, Gitanjali Adlakha-Hutcheon, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2003
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patientsF Stephen Hodi, Martin C Mihm, Robert J Soiffer, et al.
Malaria Journal|November 14, 2025
Epidemiological stratification and sub-national tailoring of malaria interventions in LiberiaVictor S Koko, D Levi Hinneh, Odell Kumeh, et al.
Journal of Clinical Microbiology|August 13, 2010
Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approachesFred C Tenover, Susan Novak-Weekley, Christopher W Woods, et al.
Nature Medicine|December 3, 2013
Self-renewal as a therapeutic target in human colorectal cancerAntonija Kreso, Peter van Galen, Nicholas M Pedley, et al.
Journal for Immunotherapy of Cancer|June 27, 2017
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31<sup>st</sup>Annual Meeting of the Society for Immunotherapy of Cancer, 2016Prasad S Adusumilli, Edward Cha, Mark Cornfeld, et al.
Pageof 10